Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | PDE4A | P27815 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8781841 | 1.00 | KDM4E (0.48) | KDM4ELMNAL3MBTL1TDP1PDE4A | |
| SCHEMBL11454828 | 0.96 | KDM4E (0.43) | KDM4ELMNAL3MBTL1TDP1PDE4A | |
| SCHEMBL19114066 | 0.82 | KDM4E (0.35) | KDM4EACHE | |
| SCHEMBL17850547 | 0.82 | KDM4E (0.31) | KDM4E | |
| SCHEMBL2535752 | 0.82 | ACHE (0.34) | KDM4EACHE | |
| SCHEMBL9444652 | 0.79 | LMNA (0.65) | KDM4ELMNAL3MBTL1TDP1PDE4A | |
| SCHEMBL5551085 | 0.79 | LMNA (0.65) | KDM4ELMNAL3MBTL1TDP1PDE4A | |
| SCHEMBL29344590 | 0.79 | LMNA (0.65) | KDM4ELMNAL3MBTL1TDP1PDE4A | |
| SCHEMBL724112 | 0.79 | LMNA (0.65) | KDM4ELMNAL3MBTL1TDP1PDE4A | |
| SCHEMBL16357689 | 0.77 | KDM4E (0.42) | KDM4ELMNAL3MBTL1TDP1PDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0618216-B1 | N-alkylisomaltamines, their preparation from isomaltulose and their application as surfactants | SUEDZUCKER AG (DE) | 1997-09-10 | — | — | EP | claimed |
| JP-55062004-A | — | — | None | — | — | JP | disclosed |
| US-20090042749-A1 | N,N-Dialkylpolyhydroxyalkylamines | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2009-02-12 | — | — | US | disclosed |
| EP-1676831-B1 | N,N-dialkylpolyhydroxyalkylamines | AIR PROD & CHEM (US) | 2008-10-08 | — | — | EP | disclosed |
| EP-1676831-A1 | N,N-dialkylpolyhydroxyalkylamines | Air Products and Chemicals, Inc. (US) | 2006-07-05 | — | — | EP | disclosed |
| US-20060100127-A1 | N,N-dialkylpolyhydroxyalkylamines | AIR PRODUCTS AND CHEMICALS, INC. | 2006-05-11 | — | — | US | disclosed |
| EP-1637038-A2 | N,N'-dialkyl derivatives of polyhydroxyalkyl alkylenediamines | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2006-03-22 | — | — | EP | disclosed |
| US-20060013780-A1 | N,N'-dialkyl derivatives of polyhydroxyalkyl alkylenediamines | AIR PRODUCTS AND CHEMICALS, INC. | 2006-01-19 | — | — | US | disclosed |
| EP-0618216-A1 | N-alkylisomaltamines, their preparation from isomaltulose and their application as surfactants | SÜDZUCKER AKTIENGESELLSCHAFT MANNHEIM/OCHSENFURT (DE) | 1994-10-05 | — | — | EP | disclosed |
| JP-S5562004-A | CONTROL AGENT AGAINST PLANT VIRAL DISEASE | KUREHA CHEM IND CO LTD | 1980-05-10 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060013780-A1 | N,N'-dialkyl derivatives of polyhydroxyalkyl alkylenediamines | AGL, SFN, MGAT1 | KDM4E 3607/4885LMNA 492/4885L3MBTL1 2608/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.